AP-105 (AP Biosciences)

N/A

Report date: 2025/03/14 16:53:02

Base Information

Drug NameAP-105 (AP Biosciences)
Drug Alias NamePD-L1 checkpoint inhibitor (AP Biosciences)AP-105
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAP Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAP Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A